Cyclacel raises $13.2M in follow-on

Cancer company Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) raised $13.2 million through the sale of 2.2 million class A units at $2 and 8,872 class B units at $1,000 in a follow-on underwritten by Ladenburg Thalmann on July 19...